Cancer Biomarkers and Translational Pathology

Cancer biomarkers are transforming diagnosis, prognosis, and therapeutic decision-making. This track focuses on predictive biomarkers, liquid biopsy, and translational research. Sessions cover genomic medicine, companion diagnostics, and biomarker validation. Experts will discuss integrating laboratory discoveries into clinical practice. Advances in precision oncology and targeted therapies will be emphasized. Emerging biomarker technologies for personalized cancer care will also be explored.

    Related Conference of Cancer Biomarkers and Translational Pathology

    March 15-16, 2027

    7th World Pathology Conference

    Amsterdam, Netherlands
    March 25-26, 2027

    25th European Pathology Congress

    Paris, France
    March 29-30, 2027

    25th Annual Pathology Congress

    Dubai, UAE

    Cancer Biomarkers and Translational Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in